Table 2.
Re-excision, surgical margin, and oncoplastic surgery status
| Preoperative boost [n = 89] | Contemporary Canadian hypofractionation patients [n = 89] | |
|---|---|---|
| Initial margin status | ||
| Positive | 6 (6.7) | 10 (11.2) |
| Close | 19 (21.3) | 22 (24.7) |
| Negative | 64 (71.9) | 57 (64.0) |
| Final margin status | ||
| Positive | 4 (4.5) | 2 (2.2) |
| Close | 18 (20.2) | 20 (22.5) |
| Negative | 67 (75.3) | 67 (75.3) |
| Re-excision | ||
| Yes | 3 (3.4) | 12 (13.5) |
| No | 86 (96.6) | 77 (86.5) |
| Oncoplastic | ||
| Yes | 24 (27.0) | 25 (28.1) |
| No | 65 (73.0) | 64 (71.9) |
| Cavity shave margins | ||
| Yes | 42 (47.2) | 67 (75.3) |
| No | 45 (50.6) | 22 (24.7) |
| No record | 2 (2.2) | |
| Intraoperative radiography | ||
| Yes | 81 (91.0) | 88 (98.9) |
| No | 6 (6.7) | 1 (1.1) |
| No record | 2 (2.2) |
Data are expressed as n (%)
Initial margin margin status after initial lumpectomy, final margin margin status at the time of radiotherapy (after any additional re-excisions if applicable), close ≤ 2 mm